However, the expression of immune checkpoints such as PD-L1, CTLA4, HAVCR2, and PD-1 was significantly up-regulated in Cluster B, as well as the higher TIDE score, indicating that this molecular subtype has a certain degree of immunosuppression, which inhibits the tumor-killing function of immune cells. This evidence concerns the gene CTLA4 and neoplasm.